
Sign up to save your podcasts
Or


One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies.
Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150
By Michael Putman4.9
113113 ratings
One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies.
Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150

322 Listeners

502 Listeners

883 Listeners

127 Listeners

1,157 Listeners

119 Listeners

193 Listeners

172 Listeners

69 Listeners

254 Listeners

4 Listeners

182 Listeners

11 Listeners

20 Listeners

5 Listeners